Free Trial

Beximco Pharmaceuticals (LON:BXP) Reaches New 52-Week High - Here's What Happened

Beximco Pharmaceuticals logo with Medical background

Shares of Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 41 ($0.55) and last traded at GBX 41 ($0.55), with a volume of 4868 shares. The stock had previously closed at GBX 39.50 ($0.53).

Beximco Pharmaceuticals Stock Performance

The company has a current ratio of 2.13, a quick ratio of 0.37 and a debt-to-equity ratio of 12.47. The stock has a market capitalization of £27.95 billion, a price-to-earnings ratio of 4.40 and a beta of 0.61. The firm's fifty day moving average price is GBX 37.17 and its 200 day moving average price is GBX 37.74.

Beximco Pharmaceuticals Company Profile

(Get Free Report)

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Beximco Pharmaceuticals Right Now?

Before you consider Beximco Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beximco Pharmaceuticals wasn't on the list.

While Beximco Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines